PARP inhibitor Therapy(SOTIO Biotech)

N/A

Report date: 2024/04/24 17:36:43

Base Information

Drug NamePARP inhibitor Therapy(SOTIO Biotech)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPoly (ADP-Ribose) polymerase inhibitors

TargetsPoly (ADP-Ribose) polymerase

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSotio Biotech Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsOvarian Neoplasms

Inactive IndicationsN/A

ATC CodeN/A